Presentation is loading. Please wait.

Presentation is loading. Please wait.

Introduction, Natural History and Pathogenesis of HIV infection Dr.K.Bujji Babu, MD. Consultant HIV Physician Bujjibabu HIV Clinic.

Similar presentations


Presentation on theme: "Introduction, Natural History and Pathogenesis of HIV infection Dr.K.Bujji Babu, MD. Consultant HIV Physician Bujjibabu HIV Clinic."— Presentation transcript:

1 Introduction, Natural History and Pathogenesis of HIV infection Dr.K.Bujji Babu, MD. Consultant HIV Physician Bujjibabu HIV Clinic

2 HIV/AIDS Historical Milestones 1981First Report of AIDS, USA 1983Discovery of HIV 1984ELISA for HIV Developed 1986HIV-2 Identified, HIV & AIDS Reported in India 1987First Antiretroviral-ZDV Approved 1989Screening Blood Units Mandatory 1991First Report of HIV-2 in India 1994ZDV Reduces MTCT - ACTG 076. Protease Inhibitors Approved by FDA 1996Discovery of Chemokine Receptors 1998Short-term ZDV for MTCT CDC-Thai 1999 Nevirapine for MTCT- HIVNET 012

3

4

5 Genome of HIV

6

7

8 Life Cycle of HIV DS dna COMPLEX Protease

9

10 HIV Entry Mechanism 3c. Fusion Complete 1. CD4 Attachment 3b. coil-coil interaction CXCR4 CCR5 HIV gp120 3a. Anchorage CD4 2. Co-receptor interaction Cell HIV gp41 HIV Slide #10

11 HIV Fusion Inhibition by T-20 Source: www.trimeris.com

12 Molecular heterogeneity of HIV 1  Catagorized into 3 groups group M ( major ) : subtypes or clades A,B,C,D,F,G,H,J :CRFs AE,AG,AGI,AB group O ( outlier ) : group N

13 HIV-1 subtypes  SUBTYPE C - PREDOMINANT  India  South Africa  Ethiopia  Botswana  Tanzania Account for a third HIV infections in world  SUBTYPE B - PREDOMINANT  America’s  Europe  Australia & New Zealand  Japan  IDUs in Thailand, China, Myanmar Account for about a tenth of HIV infections world over.

14 HIV-1 Subtypes in India NARI & other data

15 Differences in HIV-1 & HIV -2 Amino Acid Homology is between 40-60% Majority of Infections are HIV-1 (~89%), HIV- 2 (2-4%) & remaining dual Reactivity in India Transmission by sex & MTCT less efficient Immunodeficiency develops slowly & milder NNRTI not active against HIV-2 HIV-2 mainly present in West African nations, prevalence rate more than 1%; now found all over the world

16 Transmission of HIV  Sexual  Injection drug users  Blood and blood products  Maternal transmission  Occupational exposure

17 Body fluids which can transmit HIV  Blood and bloody fluids  Potentially infectious: semen, vaginal secretions, CSF, pleural, peritoneal, pericardial, amniotic fluid or tissue  CANNOT transmit: saliva, tears, sweat, non bloody urine or faeces

18 Per-contact risk estimate for sexual exposures with HIV+ and unprotected  Anal receptive 0.8 – 3.2%  Anal insertive 0.02 – 0.2%  Vaginal receptive 0.05 – 0.15%  Vaginal insertive 0.03 – 0.09%  Oral receptive 0.04%

19 Risk of transmission following accidental needle injury  Hepatitis B virus 6 – 30%  Hepatitis C virus 0 – 7%(1.8%)  HIV 0 – 0.3%

20 Typical course of HIV infected person

21 Entry through mucosal surface/blood  Dendritic cells/macrophages  Transport to regional lymph nodes  CD4 cells infected

22

23 Characteristics of acute HIV infection  Acute retroviral syndrome – 50-70% cases Fever,fatigue,rash,myalgia,pharyngitis, lymphadenopathy,night sweats, weight loss, candidiasis, oral ulcers etc.  High viral RNA - mean 12 million copies/ml  CD4 counts decline, CD8 counts rise

24 Entry of HIV into human cells  CD4+ receptor  CCR5 and CXCR-4 receptors  Cells affected : - CD4+ lymphocytes, naïve and memory (latent pool) - Macrophages/monocytes -Tissues such as CNS, testes

25 Evasion of immune system control  Mutation of virus  CD8+ CTLs – deletion of initially expanded clones due to massive viral antigen exposure  CD8+ CTLs – segregation in the peripheral blood  Large pool of latently infected cells that cannot be eliminated by CD8+ CTLs

26 Generation of latently infected CD4+T cells

27 Latently infected cells  A pool of latently infected CD4+T cells present in all HIV individuals  Established early during the course of primary HIV infection  Major obstacle to goal of eradication of virus

28 Persistent infection  Viral latency is responsible for persistence of HIV  HIV preferentially infects memory CD4 cells whose half-life varies from 6 to 43 months  Even in patients whose viral load < 50 copies/ml for 5 years, this is detectable  Transmission still occurs

29 Viral dynamics  High levels of viral replication and destruction in plasma and lymph nodes  Almost 10 billion virions produced every day  In primary HIV infection viral population is relatively homogenous  Later due to rapid replication and mutation a diverse population is produced - quasispecies

30 Viral dynamics  Half life of circulating virion 30 min  Productively infected CD4 cell – 1 day  Large amount (app. 1 billion) of virus produced and cleared form circulation each day  HIV1 replication cycle – 1.5 days

31 Dynamics of HIV infection in vivo

32 Viral ‘Set Point’  The level of viral load after seroconversion or virologic equilibrium between viral replication and immunologic containment of viral replication  Higher the set point, more rapid is disease progression  Within the first 6-12 months of infection  Initiating antiretroviral therapy may alter the set point

33 Relationship between level of virus and rate of disease progression

34

35 Long term nonprogressors  HIV infection > 10 years, CD4 cells normal range, stable over years and not received ART  They have low viral burden, low level of viremia and normal immune function  No qualitative abnormalities detected in the virus in most patients  Small subset defect in nef gene  Host factors : CCR5 – 32 deletion; CCR2 641 mutation; SDF1-3 mutation; RANTES – 28G mutation; maximal HLA heterozygosity of class 1 loci

36 Mechanism of immunosuppression  Quantitative decrease in CD4+ cells  Qualitative decrease in function: suboptimal responses to vaccines  Apoptosis  CD4+ maintained for years probably due to repletion rather than latent virus  Decline by an average of 40-80 cells/year without therapy

37 Immune responses to HIV  Activation of HIV clones of CD4 T cells and subsequent loss  CD8 cells rapidly increase in acute infection – kill infected cells and secrete chemokines  Gradual failure -‘viral escape’ - HIV actually kills T cells - decreased production

38 Summary  Primary HIV infection  Early/middle stages of disease – clinical latency is not disease latency  Advanced HIV disease – CD4 < 200 cells/ml  Late-stage HIV disease – CD4 < 50 cells/ml


Download ppt "Introduction, Natural History and Pathogenesis of HIV infection Dr.K.Bujji Babu, MD. Consultant HIV Physician Bujjibabu HIV Clinic."

Similar presentations


Ads by Google